Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02190370
Other study ID # THICS-Study 3
Secondary ID
Status Recruiting
Phase N/A
First received April 14, 2014
Last updated March 14, 2017
Start date November 2013
Est. completion date August 2017

Study information

Verified date March 2017
Source University of Cologne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose of this study is to evaluate the efficacy of a resources activation based treatment programme in children and adolescents aged 8 to 18 years with tic disorders.


Description:

The main purpose of this study is to evaluate the efficacy of an intervention aimed at the activation of resources for children and adolescents with tic disorders. The activation of resources treatment programme was developed at Department of Child and Adolescent Psychiatry and Psychotherapy at the University of Cologne and is currently evaluated in different studies.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date August 2017
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender All
Age group 8 Years to 18 Years
Eligibility Inclusion Criteria:

- 8-18 years

- Diagnosis of chronic motor or vocal Tic (F95.1) or Tourette-Syndrome (F95.2)

- YGTSS total score F95.2>13, F95.1>9

- Tics are the main problems

- IQ>80

- If medication, then has been stable for at least one months in medicated patients

- No change in medication treatment is planned

- Ability to participate in weekly outpatient treatment

- Acceptance of randomization

Exclusion Criteria:

- Diagnosis of Autism Spectrum Disorder or Psychosis

- Parallel continuous psychotherapy of tics or comorbid

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Resources activation


Locations

Country Name City State
Germany University Hospital of Cologne, Department of Childhood and Adolescent Psychiatry and Psychotherapy Cologne

Sponsors (1)

Lead Sponsor Collaborator
University of Cologne

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Perri, D., Mandler, J. & Döpfner, M. (2015). STARK - Supportive Therapie zur Aktivierung von Ressourcen. Göttingen: Hogrefe.

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Symptom Checklist for Tic-Symptoms (FBB-TIC), parent rating The FBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents Baseline (T0), after 8 weeks (T1), 16weeks (T2), 24weeks (T3)
Primary Change in self-esteem (Harter-Scale-SBB)(self rating) The Harter-Scale is used to assess self-esteem T0, after 8 weeks (T1), 24weeks (T3)
Secondary Change in Symptom Checklist for Tic-Symptoms (FBB-/SBB-TIC), Teacher-/self-rating The SBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents Baseline (T0), after 8 weeks (T1), 16 weeks (T2), 24weeks (T3)
Secondary Change in Symptom Checklist for Tic-Symptoms, clinical rating The Checklist is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by clinicians Baseline (T0), after 8 weeks (T1), 16weeks (T2), 24weeks (T3)
Secondary Change of comorbid ADHD Symptoms (FBB/SBB-ADHD), parent, teacher and self-rating The Symptom Checklist for Attention Deficit/Hyperactivity Disorder (FBB-/SBB-ADHS) assess all symptom criteria according to DSM IV and ICD-10. T0, after 8 weeks (T1), 24 weeks (T3)
Secondary Change of comorbid OCD Symptoms (ZWIK-E), parent-rating The ZWIK assess OCD criteria. T0, after 8 weeks (T1), 24weeks (T3)
Secondary Change of comorbid Symptoms (CBCL/TRF/YSR), parent-/teacher-/self-rating The CBCL, TRF and YSR assess a variation of different criteria. T0, after 8 weeks (T1), 24weeks (T3)
Secondary Change in Tic-Symptoms (YGTSS-TIC), overall score The YGTSS is used to assess Tic-Symptoms in a semi structured interview with parents and patients Baseline (T0), after 8 weeks (T1),16weeks (T2), 24weeks (T3)
Secondary Change in Tic-Symptoms (observation) Tic symptoms are observed through video tapes and are rated through clinicians Between T1 and T3 up to 16 weeks, during each session/week
See also
  Status Clinical Trial Phase
Recruiting NCT02144870 - Efficacy of Psychotherapy Treatment of Children With Tics N/A
Recruiting NCT02190383 - Efficacy of a Habit Reversal Treatment on Tic-symptoms N/A